The latest poll conducted by the KFF COVID-19 Vaccine Monitor found that nearly half of all adults in the U.S. plan to get the newly recommended COVID-19 vaccine.
ABC News: Top Stories
Almost half of US adults plan to get new COVID-19 vaccine, survey finds
Are Covid-19 vaccine cards still relevant? Here’s what experts say
Experts share when you do — and don’t — need your Covid-19 vaccine card, plus how to replace it in case it has gone missing.
CNN.com – RSS Channel – Health
Change in monkeypox vaccine injection method could mean more doses but may not be easy, experts say
The US government is considering a change to how physicians give monkeypox vaccines so it can make the most of the supply on hand, US Food and Drug Administration Commissioner Dr. Robert Califf said Thursday.
CNN.com – RSS Channel – Health
An additional 786,000 monkeypox vaccine doses will soon be available in the United States
After weeks of mounting frustration over limited supplies of monkeypox vaccines, about 786,000 additional doses are being made available in the United States, the US Department of Health and Human Services announced on Wednesday.
CNN.com – RSS Channel – Health
When will the US have a Covid-19 vaccine for the youngest children?
It’s been more than a year since adults first got Covid-19 vaccines, but about 18 million children under 5 in the US are still waiting — and will probably have to wait until the summer, despite some predictions that shots would be available in the first part of 2022.
Moderna says its Covid-19 vaccine performs as well in children as it does in adults
Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday.
One of the leading coronavirus vaccine trials is currently paused. Prominent vaccine researchers tell CNN that’s unusual
Vaccine clinical trials are notoriously difficult to conduct.
AstraZeneca’s Oxford vaccine trial to resume, the university says
The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday.
Intranasal flu vaccine with nanoparticles offers robust protection
An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers.
Latest Science News — ScienceDaily


